Answer
No. It is targeted radionuclide therapy: a receptor-binding molecule carries radioactive lutetium to susceptible tumour cells.
Sources for this answer
- Lutathera 370 MBq/mL solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.